Dow Up 0.05% Nasdaq Down 0.18%

More On ESALY

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Eisai Co., Ltd. (ESALY)

-Other OTC
60.96 Down 0.34(0.55%) May 5, 3:56PM EDT
|Pre-Market : NaN
Prev Close:61.30
Open:61.25
Bid:N/A
Ask:N/A
1y Target Est:97.39
Beta:-0.314581
Next Earnings Date:N/A
Day's Range:60.77 - 61.30
52wk Range:55.81 - 71.86
Volume:1,150
Avg Vol (3m):4,616
Market Cap:17.42B
P/E (ttm):43.39
EPS (ttm):1.41
Div & Yield:1.13 (1.81%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ESALY

Key Statistics

Forward P/E (1 yr):64.85
P/S (ttm):3.45
Ex-Dividend Date:25-Sep-15

Analysts

Annual EPS Est (Mar-16) :1.13
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):21.44

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Eisai Co., Ltd. manufactures and sells pharmaceutical products worldwide. The company offers oncology-related products, such as Halaven, an anticancer agent; Aloxi, an antiemetic agent; and Fragmin, an injectable anticlotting agent, as well as Sym... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback